SacredBod
0
Chirayata — SacredBod supplement bottle (illustrative)
Supplement · Botanical

Chirayata

500 mg · vegan · gluten-free · 60 caps

Poor digestionLow appetiteLiver congestionIntermittent feverHigh blood sugarParasitic infection LiverGallbladderDigestive systemSkin
BUY on Amazon →

Affiliate link · we earn from qualifying purchases. No paid placements.

What it is

Chirayata (Swertia chirayita Buch.-Ham.), also known as Chirata or Kiratatikta, is an annual herb in the Gentianaceae family native to the temperate Himalayas (1,200–3,000 m elevation). It is one of the most important bitter tonics in Ayurveda and traditional Tibetan medicine. The whole plant contains bitter principles (amarogentin, chiratin, swertiamarin), xanthones, and flavonoids. It is traditionally used for fever (malaria, intermittent fever), liver disorders, blood sugar dysregulation, and as a digestive bitter. It is classified as Tikta (bitter) rasa andSheet virya (cooling potency).

How it works

The bitter compounds (amarogentin, swertiamarin) stimulate bitter taste receptors (TAS2Rs) on the tongue and throughout the GI tract, triggering the cephalic phase of digestion and enhancing bile secretion. A 2026 study showed Swertia chirayita ameliorates metabolic-associated fatty liver disease (MAFLD) by improving gut microbiota diversity, restoring beneficial SCFAs (butyric, acetic, propionic acid), and upregulating intestinal tight junction proteins (ZO-1, occludin, claudin-1). It also activates FXR/FGF15 signaling to inhibit hepatic lipogenesis. Anticarcinogenic activity includes activation of detoxification enzymes (GST, GPx, SOD, CAT) and induction of apoptosis in DMBA-induced skin carcinogenesis. Clinical studies from 1986 showed 70% good response in Entamoeba histolytica cyst passers.

Who should take it

Individuals seeking bitter digestive support and liver health, those with occasional fever or parasitic concerns (under medical supervision), people with metabolic syndrome or MAFLD risk factors, and those interested in Himalayan Ayurvedic herbs. Traditionally used for 'Agnimandya' (low digestive fire) in Ayurveda.

Avoid / careful

Pregnant and breastfeeding women. Individuals with hypoglycemia or on diabetes medications (may potentiate glucose-lowering effect). Those with severe gastric ulcers or hyperacidity. Not for children under 12. Side effects: Very bitter taste may cause nausea in sensitive individuals. High doses may cause gastric irritation or diarrhea. May lower blood sugar — diabetics should monitor glucose levels. Traditional texts note it is cooling; excessive use may aggravate Vata.

When to take it

Morning
Noon
Evening
Night

How to take it

With food
Empty stomach
Before food

FAQs

Frequently asked

How long before I see results?
Digestive fire (Agni) benefits may be felt within 1–2 weeks. Liver enzyme improvements and metabolic benefits require 4–8 weeks based on animal model data.
Is it safe to take daily?
Yes at 500 mg/day. Traditional Ayurvedic practice supports regular use, though some practitioners recommend 4–6 week courses with breaks due to its intense bitter and cooling nature.
Can I take it with diabetes medication?
Consult your physician. Chirayata has demonstrated hypoglycaemic activity in animal studies and may potentiate the effect of antidiabetic drugs. Monitor blood glucose closely if combining.

In plain English

A plain-English read of the literature behind this supplement. Not a clinical recommendation.

Key citations: PMID 41802510 (MAFLD amelioration via gut microbiota and FXR/FGF15), PMID 15173996 (anticarcinogenic and detoxification enzyme activation), PMID 22557529 (clinical efficacy in amoebiasis and giardiasis)

Editorial notes

SacredBod's longer take on Chirayata — context the structured blocks above don't capture.

What It Is

Chirayata (Swertia chirayita Buch.-Ham.), also known as Chirata or Kiratatikta, is an annual herb in the Gentianaceae family native to the temperate Himalayas (1,200–3,000 m elevation). It is one of the most important bitter tonics in Ayurveda and traditional Tibetan medicine. The whole plant contains bitter principles (amarogentin, chiratin, swertiamarin), xanthones, and flavonoids. It is traditionally used for fever (malaria, intermittent fever), liver disorders, blood sugar dysregulation, and as a digestive bitter. It is classified as Tikta (bitter) rasa andSheet virya (cooling potency).

How It Works

The bitter compounds (amarogentin, swertiamarin) stimulate bitter taste receptors (TAS2Rs) on the tongue and throughout the GI tract, triggering the cephalic phase of digestion and enhancing bile secretion. A 2026 study showed Swertia chirayita ameliorates metabolic-associated fatty liver disease (MAFLD) by improving gut microbiota diversity, restoring beneficial SCFAs (butyric, acetic, propionic acid), and upregulating intestinal tight junction proteins (ZO-1, occludin, claudin-1). It also activates FXR/FGF15 signaling to inhibit hepatic lipogenesis. Anticarcinogenic activity includes activation of detoxification enzymes (GST, GPx, SOD, CAT) and induction of apoptosis in DMBA-induced skin carcinogenesis. Clinical studies from 1986 showed 70% good response in Entamoeba histolytica cyst passers.

Who Should Consider It

Individuals seeking bitter digestive support and liver health, those with occasional fever or parasitic concerns (under medical supervision), people with metabolic syndrome or MAFLD risk factors, and those interested in Himalayan Ayurvedic herbs. Traditionally used for ‘Agnimandya’ (low digestive fire) in Ayurveda.

Dosage Guide

Typical dose: 500 mg per day

Form: capsules (60 count)

Best time: morning

With food: with-food

Expected onset: 2–4 weeks for digestive and liver support; 4–8 weeks for metabolic benefits

Cycling: No cycling required. Traditional use supports continuous daily intake, though bitter herbs are often used in 4–6 week courses.

Safety & Side Effects

Known side effects: Very bitter taste may cause nausea in sensitive individuals. High doses may cause gastric irritation or diarrhea. May lower blood sugar — diabetics should monitor glucose levels. Traditional texts note it is cooling; excessive use may aggravate Vata.

Who should avoid: Pregnant and breastfeeding women. Individuals with hypoglycemia or on diabetes medications (may potentiate glucose-lowering effect). Those with severe gastric ulcers or hyperacidity. Not for children under 12.

Avoid combining with: Hypoglycaemic drugs, Anticoagulants (theoretical), Immunosuppressants

India-Specific Context

Chirayata is available on Amazon India with several Ayurvedic and herbal brands. The primary ASIN listed is a verified product matching the supplement name. Indian consumers should look for products from GMP-certified manufacturers. Traditional Ayurvedic practitioners (Vaidyas) often prescribe this herb in combination with other classical formulations rather than as a standalone supplement.

Sanskrit/Hindi names: See quick facts above.

Classical Ayurvedic texts: Chirayata is referenced in Charaka Samhita and/or Sushruta Samhita as detailed in the quick facts.

Schedule status: Not a Schedule H drug in India; available as dietary supplement/herbal product.

Research Summary

Key citations: PMID 41802510 (MAFLD amelioration via gut microbiota and FXR/FGF15), PMID 15173996 (anticarcinogenic and detoxification enzyme activation), PMID 22557529 (clinical efficacy in amoebiasis and giardiasis)

Evidence grade: C — Limited human clinical data; strong animal and in-vitro evidence

Added to your stack.